{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:57:28Z","timestamp":1790621848014,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011960","name":"DEBRA International","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DEBRA Austria","award":["SAF2013-43475-R"],"award-info":[{"award-number":["SAF2013-43475-R"]}]},{"name":"DEBRA Austria","award":["SAF2017-86810-R"],"award-info":[{"award-number":["SAF2017-86810-R"]}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"crossref","award":["PI14\/00931"],"award-info":[{"award-number":["PI14\/00931"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"crossref","award":["PI17\/01747"],"award-info":[{"award-number":["PI17\/01747"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Regional Development Funds"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.omtn.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T14:51:09Z","timestamp":1517410269000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells"],"prefix":"10.1016","volume":"11","author":[{"given":"\u00c1ngeles","family":"Menc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bonafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Holguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Illera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara G.","family":"Llames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Esc\u00e1mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Murillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2018.01.009_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2018.01.009_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound\u00a0through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2018.01.009_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2018.01.009_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/humc.2014.083","article-title":"HEK293-based production platform for \u03b3-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA","volume":"25","author":"Hennig","year":"2014","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtn.2018.01.009_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib8","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic\u00a0correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.omtn.2018.01.009_bib9","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.009_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jid.2015.11.028","article-title":"Meganuclease-mediated COL7A1 gene correction for recessive dystrophic epidermolysis bullosa","volume":"136","author":"Izmiryan","year":"2016","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib11","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1038\/mtna.2016.19","article-title":"Gene editing for the efficient correction of a recurrent COL7A1 mutation in recessive dystrophic epidermolysis bullosa keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2018.01.009_bib12","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14712598.2017.1271872","article-title":"Exon skipping: a first in class strategy for Duchenne muscular dystrophy","volume":"17","author":"Niks","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-767-5_15","article-title":"Antisense-mediated\u00a0exon skipping to reframe transcripts","volume":"867","author":"Turczynski","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2018.01.009_bib15","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in\u00a0vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib16","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1038\/mtna.2016.87","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2018.01.009_bib17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/mt.2016.92","article-title":"Analysis of the functional consequences of targeted exon deletion in\u00a0COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy","volume":"24","author":"Bornert","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mt.2014.234","article-title":"Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases","volume":"23","author":"Ousterout","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib19","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","article-title":"Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients","volume":"21","author":"Ousterout","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.01.009_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In\u00a0vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.01.009_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In\u00a0vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2018.01.009_bib23","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.1614775114","article-title":"Efficient in\u00a0vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2018.01.009_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.15252\/emmm.201404353","article-title":"A single epidermal stem cell strategy for safe ex\u00a0vivo gene therapy","volume":"7","author":"Droz-Georget Lathion","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2018.01.009_bib25","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/mt.2014.187","article-title":"Long-term skin regeneration from a gene-targeted human epidermal stem cell clone","volume":"22","author":"Duarte","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib26","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.mt.6300238","article-title":"Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy","volume":"15","author":"Larcher","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/515495","article-title":"Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation","volume":"61","author":"Hovnanian","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.01.009_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Esc\u00e1mez","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib29","first-page":"169","article-title":"Heteroduplex formation in polymerase chain reaction","volume":"47","author":"Anglani","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2018.01.009_bib30","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2018.01.009_bib31","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1093\/nar\/gkt1326","article-title":"An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage","volume":"42","author":"Fine","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2018.01.009_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jdermsci.2011.11.010","article-title":"Novel and recurrent COL7A1 mutations in Chilean patients with dystrophic epidermolysis bullosa","volume":"65","author":"Rodr\u00edguez","year":"2012","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.omtn.2018.01.009_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/scrt449","article-title":"The\u00a0effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional","volume":"5","author":"Chapman","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtn.2018.01.009_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/exd.12203","article-title":"Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in\u00a0vitro and in\u00a0vivo","volume":"22","author":"Chamorro","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.omtn.2018.01.009_bib35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.TP.0000112381.80964.85","article-title":"Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin","volume":"77","author":"Llames","year":"2004","journal-title":"Transplantation"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253118300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:14:41Z","timestamp":1772226881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253118300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":35,"alternative-id":["S2162253118300106"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2018.01.009","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}